Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-04-000025

Options or other derivatives

  • Director acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RATHMANN GEORGE B · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2004-08-31 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +1,000 $8.60 2014-08-30 1,000 1,000 D
Loading xslF345X02/edgar.xml…